GOCO GoHealth, Inc.
Q3 2025 10-Q
GoHealth, Inc. (GOCO) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 14, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New risk: issuance of 4.77M Class A shares (16.66% post-closing) to lenders may pressure stock price upon resale or perception of resale
- • Material update: strategic capital and governance actions on August 6, 2025, enable pursuing mergers, acquisitions, refinancing, increasing financial flexibility
Quarterly Financial SummaryXBRL
Revenue
$34M
▼ -71.1% YoY▼ -63.7% QoQ
Net Income
-$166M
▼ -2547.9% YoY▼ -205.6% QoQ
Operating Margin
-842.2%
▼ -80613bp YoY▼ -73653bp QoQ
Net Margin
-485.1%
▼ -49086bp YoY▼ -42742bp QoQ
ROE
-243.3%
Total Assets
$1.0B
EPS (Diluted)
$-13.42
▼ -2264.5% YoY▼ -158.1% QoQ
Operating Cash Flow
-$33M
▼ -167.0% YoY▲ +13.7% QoQ
Source: XBRL data from GoHealth, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on GoHealth, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.